🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareSELECT trial 4-year follow-up data released — sustained MACE reduction Page 2

SELECT trial 4-year follow-up data released — sustained MACE reduction

Dr.CardioMD Fri, Mar 13, 2026 at 11:48 AM 16 replies 240 viewsPage 2 of 4
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Mar 13, 2026 at 2:38 PM#6

Subscribing to this thread. SELECT trial 4-year data is exactly what I've been researching. 🙏

Last edited: Mar 13, 2026 at 7:38 PM
19 2lucas_SP_BR, lisa_labSD, adam_van and 16 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Mar 13, 2026 at 2:55 PM#7

As a pharmacist, I want to add some clinical context to this discussion on SELECT trial 4-year data released .

Building on what DataDave said — the evidence base here is robust. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
42 22PharmD_Rodriguez, julia.endo, JessicaM_2024 and 39 others
Reply Quote Save Share Report
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
Mar 13, 2026 at 3:12 PM#8

Reading this thread on SELECT trial 4-year data hits close to home. Dad of 2 checking in — I started at 261 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 36 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about SELECT trial 4-year — take the leap. It was the best health decision I have ever made. ❤️

47 18pam_columbus, nick_SD_fit, ben_calgary and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Mar 13, 2026 at 3:29 PM#9

andrew_nyc — that is really helpful context on SELECT trial 4-year data. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

4 14PharmHunterJen, TomTeleRx, DoseLogDan and 1 other
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Mar 13, 2026 at 3:46 PM#10

To answer wanda_boise's question specifically:

From a clinical standpoint, SELECT trial 4-year data is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

48 0carl_compliance, DanielChem_CHI, marco_milano and 45 others
Reply Quote Save Share Report

Similar Threads

GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
What I wish I knew before starting GLP-1 therapy14 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register